Navigation Links
REC. PROTEIN G - SEPHAROSE from Invitrogen

ProductsREC. PROTEIN G - SEPHAROSE from Invitrogen
Company Invitrogen
Item REC. PROTEIN G - SEPHAROSE
Price 
Description Protein A and Protein G bind specifically to Fc regions of many mammalian immunoglobulins. Protein A and Protein G conjugates are commonly used as affinity adsorbents to purify immunoglobulins (antibodies) and immunoglobulin subtypes from serum, hybridoma ascites fluids, tissue culture supernatants and other biological fluids. These reagents are also commonly used to capture immune complexes generated in immunoprecipitation experiments. Because Protein A and Protein G vary widely in their abilities to bind individual immunoglobulins, consult the table below before proceeding with your application. It should be noted that the Fc binding characteristics of naturally produced Protein A and Protein G are identical to their recombinant counterparts. However, also note that Zymeds recombinant Protein G products are deleted for two albumin binding sites present in the wild type molecule. For certain procedures, it may be advantageous to use a light chain binding reagent (e.g. Zymeds Kappalock products) instead of Protein A or Protein G.
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. REC PROTEIN A - HRP from Invitrogen
2. REC PROTEIN A - SEPHAROSE from Invitrogen
3. REC. PROTEIN G - SEPHAROSE from Invitrogen
4. PROTEINEER sp: Automated Spot Picker from Bruker Daltonics
5. GUIDE TO PROTEIN PURIFICA from Pierce Biotechnology, Inc.
6. PROTEIN PROTOCOLS Book from Pierce Biotechnology, Inc.
7. Mouse Anti-Bovine GTP BINDING PROTEIN Monoclonal Antibody, Unconjugated, Clone 1H6 from AbD Serotec
8. PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
9. REC PROTEIN A from Invitrogen
10. REC. PROTEIN G from Invitrogen
11. Blasticidin S HCl from Invitrogen
... designed to allow neomycin/kanamycin selection in ... loxP-PGK-gb2-neo-loxP template encodes the neomycin/kanamycin resistance ... (gb2) for expression of kanamycin resistance ... (PGK) for expression of neomycin resistance ...
... provides a simple and efficient means for ... lture using annexin V magnetic beads (MagBeads). ... protein with high affinity for phosphatidylseri ... simple and efficient means for isolation of ...
... is tailored to highly enrich ... of rat spleen cells. Cells ... (or compatible 0.5 Tesla) immunomagnetic ... CD4+ T cell content of ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
Biology Products:
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: